NEXTHERA CAPITAL LP 13F Holdings
CIK 0001646343 · NEW YORK, NY
As of Jun 30, 2019, NEXTHERA CAPITAL LP reported 23 positions worth
CIK 0001646343 · NEW YORK, NY
As of Jun 30, 2019, NEXTHERA CAPITAL LP reported 23 positions worth
20.1K in its SEC Form 13F filing.
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| INTERCEPT PHARMACEUTICALS IN | — | — | 152,441 | 2.1K | 10.10% |
| INSMED INC | INSM | Healthcare | 470,741 | 2.1K | 10.04% |
| AUDENTES THERAPEUTICS INC. | BOLD1 | Healthcare | 294,013 | 1.1K | 9.27% |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 92,380 | $7.8K | 6.50% |
| SAREPTA THERAPEUTICS INC | SRPT | Healthcare | 50,317 | $7.6K | 6.37% |
| GLOBAL BLOOD THERAPEUTICS INC | GBT | Healthcare | 142,305 | $7.5K | 6.23% |
| IMMUNOMEDICS INC | IMMU | Healthcare | 524,140 | $7.3K | 6.06% |
| COHERUS ONCOLOGY INC | CHRS | Healthcare | 316,316 | $7.0K | 5.82% |
| ASCENDIS PHARMA A | ASND | Healthcare | 60,266 | $6.9K | 5.78% |
| PACIRA BIOSCIENCES INC | PCRX | Healthcare | 149,086 | $6.5K | 5.40% |
| UROGEN PHARMA LTD | URGN | Healthcare | 176,866 | $6.4K | 5.29% |
| UNIQURE NV | QURE | Healthcare | 59,883 | $4.7K | 3.90% |
| AMARIN CORP ADR | AMRN | Healthcare | 230,295 | $4.5K | 3.72% |
| ABBVIE INC | ABBV | Equity | 52,681 | $3.8K | 3.19% |
| Biohaven Pharmactl Hldg Co L | — | — | 86,165 | $3.8K | 3.14% |
| MYLAN N V | — | — | 102,560 | $2.0K | 1.63% |
| INTRA-CELLULAR THERAPIES INC | ITCI | Healthcare | 143,665 | .9K | 1.55% |
| REGENERON PHARMACEUTICALS INC | REGN | Healthcare | 5,668 | .8K | 1.48% |
| MADRIGAL PHARMACEUTICALS INC | MDGL | Healthcare | 15,423 | .6K | 1.35% |
| DERMIRA INC | DERM2 | Healthcare | 138,102 | .3K | 1.10% |
| GILEAD SCIENCES INC | GILD | Healthcare | 18,697 | .3K | 1.05% |
| ANAPTYSBIO INC | ANAB | Healthcare | 12,026 | $679.0 | 0.57% |
| ALLERGAN PLC | — | — | 3,347 | $560.0 | 0.47% |